OFFICIAL PUBLICATION OF

by its subsidiary APPco

New drug: Erenumab for migraine

08/11/2018

Learn more about this new option for people who have frequent attacks of migraine Injections of erenumab have recently been added to the list of drugs used for prophylaxis of frequent migraine attacks. The drug is listed as Schedule 4 by the TGA. Other options for migraine treatment include amitriptyline, pizotifen and propranolol, explains a

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Pharmacists key to relieving pressure on health system

Over the last three decades I have seen the slow erosion in the viability of small general practice. Superclinics have…

Michael Khoo

Pharmacists key to relieving pressure on health system

Realistically it will take a decade or more to fix the GP shortage. They need to make the career choice…

Ben Wishaw

Pharmacists key to relieving pressure on health system

Politician: we have a GP crisis Same politician: Let’s not fix it, let’s do something else instead.

John Smith

Concerns over pharmacy ECP accessibility

If pharmacists are giving ulipristal as first line for emergency contraception, the only way a pharmacy’s going to have expiring…

Benjamin Kop

New drug: Erenumab for migraine

Previous GP stands trial accused of attempting to murder pharmacist

Next Let us help

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

MENU

Previous GP stands trial accused of attempting to murder pharmacist

Next Let us help

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.